HoLEP is considered a gold standard treatment for Benign Prostatic Hyperplasia (BPH) and represents a successful, safe and durable treatment for this condition with a lower recurrence rate on long-term follow-up.1
Lumenis is recognized as the company that supports, promotes and contributes the most to the adoption of HoLEP. This unique recognition has been obtained due to Lumenis’ ongoing support of HoLEP for over 15 years.
Augmenting to this commitment, Lumenis is now offering a comprehensive new set of tools, especially designed to make the procedure:
> More cost effective
HoLEP training courses with the HoLEP WET simulator are available worldwide throughout the entire year.
The courses are comprehensive scientific meetings for clinicians and nursing staff, provided by well recognized experts, and include hands-on training on the simulator, live or video-urology surgeries and presentations.
1. Hazem M. Elmansy, Ahmed Kotb and Mostafa M. Elhilali, Holmium Laser Enucleation of the Prostate: Long-Term Durability of Clinical Outcomes and Complication Rates During 10 Years of Followup, The Journal of Urology, 2011, 186:1972-1976.